Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · IEX Real-Time Price · USD
1.330
-0.090 (-6.34%)
Mar 28, 2024, 12:51 PM EDT - Market open

Ekso Bionics Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Net Income
-15.2-15.08-9.76-15.83-12.13-26.99-29.12-33.82-24.25-33.77
Upgrade
Depreciation & Amortization
1.70.891.020.620.691.521.751.860.930.75
Upgrade
Share-Based Compensation
1.862.552.332.412.262.872.413.121.731.14
Upgrade
Other Operating Activities
-0.41-3.04-4.744.04-6.590.44-6.27-6.5-1.3416.87
Upgrade
Operating Cash Flow
-12.05-14.69-11.16-8.76-15.77-22.17-31.23-25-18.27-15.01
Upgrade
Capital Expenditures
-0.16-0.18-0.060-0.06-0.13-0.46-1.1-1.49-1.49
Upgrade
Acquisitions
0-500000000
Upgrade
Investing Cash Flow
-0.16-5.18-0.060-0.06-0.13-0.46-1.1-1.49-1.49
Upgrade
Share Issuance / Repurchase
0.66038.7110.4221.424.4542.6216.630.2843.48
Upgrade
Debt Issued / Paid
-0.31000.29-2.38-2.17-0.056.85-0.06-2.6
Upgrade
Other Financing Activities
--------0.1713.91-
Upgrade
Financing Cash Flow
0.35038.7110.719.042.2742.5723.3114.1240.88
Upgrade
Exchange Rate Effect
-0.02-0.020.050.040.01-0.140.080.08-00
Upgrade
Net Cash Flow
-11.89-19.8827.541.993.22-20.1610.97-2.71-5.6424.39
Upgrade
Free Cash Flow
-12.21-14.86-11.22-8.76-15.83-22.3-31.68-26.09-19.76-16.49
Upgrade
Free Cash Flow Margin
-66.80%-115.11%-99.72%-98.57%-113.76%-196.75%-430.87%-183.48%-228.16%-309.63%
Upgrade
Free Cash Flow Per Share
-0.88-1.15-0.92-1.22-3.30-5.46-13.35-21.59-20.29-22.13
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).